HRouhani
TL1 Member · Ipswich, UK
Newer member working through the reference pages before asking anything.
Joined 20 June 2025 · last posted 3d
32Posts here
0Topics
0Solutions
100Likes received
64Likes given
10Badges
91Days visited
456Posts read
Recent activity
Full stream-
I joined for one answer and stayed for a year — what changed my mind Replied, post #107 · Start Here › Welcome · 25 Jul 2026 · 8 likes First week here. The thing I would tell someone arriving behind me is that the answers are slower and much better than anywhere else I have looked, and that trying to…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #25 · Practice › Interactions · 14 Jul 2026 · 22 likes A note on scope: what I am saying about Delayed gastric emptying and oral applies to the case in the first post and I would not extend it further without checking.
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #37 · Outcomes › Body composition · 30 Jun 2026 · 19 likes The thing about ultrasound and skinfolds that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #54 · Practice › Interactions · 18 Mar 2026 · 3 likes Following this. I have the same question and no better information than the first post.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #143 · Compounds › Semaglutide · 13 Mar 2026 · 3 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
The headache that turns out to be dehydration Replied, post #149 · Nutrition & Training › Hydration & electrolytes · 22 Jan 2026 · 2 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm. If this contradicts something upthread,…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #107 · Compounds › Oral incretins · 23 Dec 2025 · 19 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #34 · Analytics › Impurities & related substances · 21 Nov 2025 · 9 likes A request rather than an answer: could whoever has the primary source for Aggregates post it? I have seen the claim three times this month and each version had lost a…
-
Revisiting: Reading order for a first week here, and what to skip until later Replied, post #2 · Start Here › Welcome · 19 Nov 2025 · 1 like First week here. The thing I would tell someone arriving behind me is that the answers are slower and much better than anywhere else I have looked, and that trying to…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #117 · Safety › Adverse events · 10 Nov 2025 · 30 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Long-time reader, first-time poster Replied, post #8 · Lounge › Introductions · 7 Nov 2025 · 7 likes New, no scientific background at all, and slightly intimidated by the first three topics I opened. Is there a sensible on-ramp for someone who is here for practical…
-
Payment method and the leverage it gives you, ranked Replied, post #72 · Sourcing › Payments · 25 Sep 2025 · 21 likes Narrowing post #71, because the general version has more than one answer. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you…